| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 21 | 2016 | 911 | 2.260 |
Why?
|
| Hippocampus | 19 | 2016 | 471 | 1.580 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 10 | 2013 | 52 | 1.350 |
Why?
|
| Memory, Short-Term | 8 | 2016 | 79 | 1.260 |
Why?
|
| Maze Learning | 18 | 2016 | 138 | 1.030 |
Why?
|
| Down Syndrome | 11 | 2015 | 120 | 0.910 |
Why?
|
| Substantia Nigra | 5 | 2010 | 102 | 0.910 |
Why?
|
| Brain-Derived Neurotrophic Factor | 8 | 2015 | 124 | 0.900 |
Why?
|
| Dopamine | 7 | 2015 | 474 | 0.890 |
Why?
|
| Tyrosine 3-Monooxygenase | 6 | 2010 | 71 | 0.880 |
Why?
|
| Nerve Growth Factor | 9 | 2006 | 54 | 0.880 |
Why?
|
| Parkinsonian Disorders | 4 | 2013 | 43 | 0.820 |
Why?
|
| Neurons | 11 | 2015 | 881 | 0.790 |
Why?
|
| Alzheimer Disease | 10 | 2014 | 565 | 0.750 |
Why?
|
| Progesterone | 3 | 2004 | 115 | 0.670 |
Why?
|
| Rats, Inbred F344 | 18 | 2016 | 104 | 0.640 |
Why?
|
| Animals | 51 | 2016 | 20881 | 0.570 |
Why?
|
| Motor Activity | 8 | 2015 | 621 | 0.550 |
Why?
|
| Neurodegenerative Diseases | 4 | 2015 | 102 | 0.550 |
Why?
|
| Dietary Fats | 4 | 2011 | 103 | 0.550 |
Why?
|
| Brain Chemistry | 4 | 2003 | 173 | 0.540 |
Why?
|
| Methamphetamine | 2 | 2008 | 132 | 0.540 |
Why?
|
| Disease Models, Animal | 16 | 2015 | 2550 | 0.540 |
Why?
|
| Corpus Striatum | 6 | 2010 | 279 | 0.530 |
Why?
|
| Brain | 12 | 2015 | 2176 | 0.510 |
Why?
|
| Behavior, Animal | 9 | 2015 | 470 | 0.510 |
Why?
|
| Memory | 5 | 2016 | 214 | 0.500 |
Why?
|
| Minocycline | 4 | 2008 | 61 | 0.490 |
Why?
|
| Cholesterol | 4 | 2016 | 331 | 0.490 |
Why?
|
| Nerve Growth Factors | 4 | 2007 | 75 | 0.470 |
Why?
|
| Neuroprotective Agents | 7 | 2015 | 317 | 0.450 |
Why?
|
| Rats | 21 | 2016 | 5300 | 0.440 |
Why?
|
| Memory Disorders | 7 | 2015 | 111 | 0.420 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 2 | 2008 | 7 | 0.400 |
Why?
|
| Cholinergic Fibers | 6 | 2010 | 27 | 0.400 |
Why?
|
| Microglia | 8 | 2016 | 143 | 0.400 |
Why?
|
| Cognition | 5 | 2015 | 513 | 0.390 |
Why?
|
| Ovariectomy | 3 | 2004 | 49 | 0.360 |
Why?
|
| Amyloid beta-Peptides | 4 | 2015 | 191 | 0.350 |
Why?
|
| Mice | 22 | 2015 | 8474 | 0.350 |
Why?
|
| Encephalitis | 2 | 2016 | 43 | 0.350 |
Why?
|
| Brain Tissue Transplantation | 6 | 2010 | 10 | 0.340 |
Why?
|
| Age Factors | 13 | 2016 | 1864 | 0.340 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2010 | 154 | 0.330 |
Why?
|
| Estrogens | 2 | 2004 | 173 | 0.320 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2008 | 22 | 0.320 |
Why?
|
| Dopamine Agents | 1 | 2008 | 56 | 0.310 |
Why?
|
| Mice, Knockout | 8 | 2014 | 1692 | 0.310 |
Why?
|
| Nerve Degeneration | 7 | 2010 | 134 | 0.300 |
Why?
|
| Immunohistochemistry | 9 | 2011 | 1174 | 0.300 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2008 | 115 | 0.300 |
Why?
|
| Nervous System | 2 | 2009 | 45 | 0.290 |
Why?
|
| Down-Regulation | 3 | 2008 | 447 | 0.290 |
Why?
|
| Frontal Lobe | 4 | 2003 | 156 | 0.280 |
Why?
|
| Space Perception | 2 | 2003 | 44 | 0.280 |
Why?
|
| Estradiol | 3 | 2004 | 176 | 0.280 |
Why?
|
| Spatial Memory | 1 | 2016 | 9 | 0.280 |
Why?
|
| Actigraphy | 2 | 2014 | 28 | 0.270 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 81 | 0.270 |
Why?
|
| Phagocytosis | 1 | 2015 | 65 | 0.260 |
Why?
|
| Cognition Disorders | 3 | 2014 | 342 | 0.260 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 221 | 0.250 |
Why?
|
| Diet | 3 | 2011 | 514 | 0.250 |
Why?
|
| Nicotinic Agonists | 1 | 2006 | 111 | 0.250 |
Why?
|
| Gonadal Hormones | 1 | 2004 | 1 | 0.240 |
Why?
|
| Motion | 1 | 2014 | 24 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2010 | 507 | 0.240 |
Why?
|
| Analysis of Variance | 6 | 2010 | 1040 | 0.230 |
Why?
|
| Lipids | 1 | 2015 | 298 | 0.230 |
Why?
|
| Blueberry Plants | 3 | 2010 | 5 | 0.230 |
Why?
|
| Peptide Fragments | 1 | 2015 | 483 | 0.220 |
Why?
|
| Locus Coeruleus | 4 | 2015 | 55 | 0.220 |
Why?
|
| Movement | 1 | 2014 | 179 | 0.220 |
Why?
|
| Growth Substances | 1 | 2003 | 77 | 0.210 |
Why?
|
| Nicotine | 1 | 2006 | 350 | 0.210 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 244 | 0.210 |
Why?
|
| Fetal Tissue Transplantation | 3 | 2005 | 12 | 0.200 |
Why?
|
| Cell Count | 4 | 2015 | 248 | 0.200 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2011 | 9 | 0.200 |
Why?
|
| Dentate Gyrus | 1 | 2011 | 13 | 0.200 |
Why?
|
| Models, Biological | 3 | 2014 | 981 | 0.190 |
Why?
|
| Spatial Behavior | 3 | 2007 | 18 | 0.190 |
Why?
|
| Cerebral Cortex | 2 | 2008 | 415 | 0.190 |
Why?
|
| Heterozygote | 3 | 2010 | 174 | 0.190 |
Why?
|
| Male | 25 | 2016 | 37321 | 0.190 |
Why?
|
| Body Weight | 4 | 2016 | 554 | 0.180 |
Why?
|
| Neuroglia | 1 | 2011 | 136 | 0.180 |
Why?
|
| Female | 20 | 2015 | 38074 | 0.180 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2009 | 4 | 0.170 |
Why?
|
| Cholesterol, Dietary | 2 | 2011 | 22 | 0.170 |
Why?
|
| Biogenic Monoamines | 1 | 2009 | 18 | 0.170 |
Why?
|
| Neurosciences | 1 | 2009 | 15 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 6 | 2014 | 2791 | 0.170 |
Why?
|
| Neostriatum | 2 | 2010 | 60 | 0.160 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 134 | 0.150 |
Why?
|
| Neural Pathways | 3 | 2008 | 324 | 0.150 |
Why?
|
| Body Temperature | 2 | 2008 | 116 | 0.150 |
Why?
|
| Norepinephrine | 3 | 2015 | 276 | 0.150 |
Why?
|
| Basal Nucleus of Meynert | 1 | 2006 | 6 | 0.140 |
Why?
|
| Graft Survival | 3 | 2010 | 465 | 0.140 |
Why?
|
| Plant Extracts | 2 | 2010 | 122 | 0.140 |
Why?
|
| tau Proteins | 3 | 2016 | 61 | 0.140 |
Why?
|
| Trisomy | 5 | 2010 | 47 | 0.140 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 1033 | 0.140 |
Why?
|
| Diet, Western | 1 | 2016 | 17 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2016 | 114 | 0.140 |
Why?
|
| Anesthetics | 1 | 2016 | 30 | 0.130 |
Why?
|
| Midazolam | 1 | 2016 | 46 | 0.130 |
Why?
|
| Indans | 1 | 2015 | 20 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2016 | 239 | 0.130 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 1293 | 0.130 |
Why?
|
| Cell Survival | 3 | 2015 | 901 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 247 | 0.130 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2015 | 10 | 0.130 |
Why?
|
| Anterior Chamber | 1 | 2005 | 20 | 0.120 |
Why?
|
| Clozapine | 1 | 2015 | 46 | 0.120 |
Why?
|
| Parkinson Disease | 2 | 2015 | 272 | 0.120 |
Why?
|
| Sensation Disorders | 1 | 2014 | 14 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2016 | 1200 | 0.120 |
Why?
|
| Synaptosomes | 2 | 2010 | 57 | 0.120 |
Why?
|
| Models, Animal | 4 | 2014 | 252 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 65 | 0.120 |
Why?
|
| Neurotrophin 3 | 2 | 2004 | 7 | 0.120 |
Why?
|
| Movement Disorders | 1 | 2014 | 58 | 0.120 |
Why?
|
| Image Enhancement | 1 | 2014 | 143 | 0.120 |
Why?
|
| Biomarkers | 5 | 2014 | 1593 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 237 | 0.110 |
Why?
|
| Locomotion | 2 | 2015 | 135 | 0.100 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 247 | 0.100 |
Why?
|
| Lipopolysaccharides | 2 | 2010 | 455 | 0.100 |
Why?
|
| Chromosomes, Mammalian | 3 | 2010 | 8 | 0.100 |
Why?
|
| Inflammation | 2 | 2014 | 1030 | 0.100 |
Why?
|
| Septum of Brain | 2 | 2005 | 2 | 0.100 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2011 | 17 | 0.100 |
Why?
|
| Leukocyte Common Antigens | 2 | 2008 | 41 | 0.100 |
Why?
|
| Walking | 1 | 2013 | 241 | 0.090 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2010 | 9 | 0.090 |
Why?
|
| Synaptic Vesicles | 1 | 2010 | 18 | 0.090 |
Why?
|
| Mice, Neurologic Mutants | 4 | 2015 | 23 | 0.090 |
Why?
|
| Pregnancy | 3 | 2010 | 2334 | 0.090 |
Why?
|
| Microdialysis | 1 | 2010 | 147 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2010 | 121 | 0.090 |
Why?
|
| Memantine | 1 | 2010 | 10 | 0.090 |
Why?
|
| Potassium | 1 | 2010 | 168 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2010 | 626 | 0.090 |
Why?
|
| Humans | 15 | 2015 | 68618 | 0.090 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 82 | 0.090 |
Why?
|
| Postural Balance | 1 | 2010 | 93 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 381 | 0.090 |
Why?
|
| Tocopherols | 1 | 2008 | 7 | 0.080 |
Why?
|
| Photomicrography | 1 | 2008 | 14 | 0.080 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 567 | 0.080 |
Why?
|
| Entorhinal Cortex | 2 | 2015 | 11 | 0.080 |
Why?
|
| Biomechanical Phenomena | 2 | 2014 | 368 | 0.080 |
Why?
|
| Acetylcholine | 2 | 2008 | 64 | 0.080 |
Why?
|
| Prosencephalon | 2 | 2008 | 38 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 756 | 0.080 |
Why?
|
| Vitamins | 1 | 2008 | 134 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2008 | 222 | 0.070 |
Why?
|
| Galantamine | 1 | 2007 | 9 | 0.070 |
Why?
|
| Serotonin | 1 | 2007 | 144 | 0.070 |
Why?
|
| Affect | 1 | 2008 | 218 | 0.070 |
Why?
|
| Escape Reaction | 2 | 2004 | 10 | 0.070 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2007 | 58 | 0.070 |
Why?
|
| Calbindin 1 | 1 | 2016 | 6 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2007 | 396 | 0.070 |
Why?
|
| Spectrophotometry | 1 | 2006 | 54 | 0.070 |
Why?
|
| Staurosporine | 1 | 2015 | 19 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2003 | 181 | 0.070 |
Why?
|
| Postmortem Changes | 1 | 2015 | 15 | 0.070 |
Why?
|
| Cotinine | 1 | 2006 | 40 | 0.070 |
Why?
|
| Blood-Brain Barrier | 2 | 2011 | 99 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2016 | 79 | 0.070 |
Why?
|
| Cholesterol, HDL | 2 | 2011 | 112 | 0.070 |
Why?
|
| Mice, Mutant Strains | 4 | 2010 | 166 | 0.060 |
Why?
|
| Perception | 1 | 2007 | 189 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 120 | 0.060 |
Why?
|
| Triglycerides | 2 | 2011 | 184 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 139 | 0.060 |
Why?
|
| Clinical Trials as Topic | 3 | 2014 | 848 | 0.060 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2004 | 9 | 0.060 |
Why?
|
| Immunotoxins | 1 | 2004 | 23 | 0.060 |
Why?
|
| Receptors, Lipoxin | 1 | 2014 | 3 | 0.060 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2014 | 4 | 0.060 |
Why?
|
| Lipoxins | 1 | 2014 | 4 | 0.060 |
Why?
|
| Plant Proteins | 1 | 2004 | 48 | 0.060 |
Why?
|
| Docosahexaenoic Acids | 1 | 2014 | 12 | 0.060 |
Why?
|
| Lipoxygenase | 1 | 2014 | 13 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2004 | 289 | 0.060 |
Why?
|
| Reward | 1 | 2005 | 201 | 0.060 |
Why?
|
| Conditioning, Operant | 1 | 2005 | 241 | 0.060 |
Why?
|
| Monitoring, Ambulatory | 1 | 2014 | 84 | 0.060 |
Why?
|
| Dihydrotestosterone | 1 | 2003 | 13 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 142 | 0.050 |
Why?
|
| Testosterone | 1 | 2003 | 96 | 0.050 |
Why?
|
| Environment, Controlled | 1 | 2002 | 9 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 234 | 0.050 |
Why?
|
| Phenotype | 1 | 2015 | 947 | 0.050 |
Why?
|
| Mental Recall | 1 | 2003 | 72 | 0.050 |
Why?
|
| Receptor, trkA | 2 | 2006 | 13 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2004 | 269 | 0.050 |
Why?
|
| Mice, Inbred C3H | 2 | 2014 | 134 | 0.050 |
Why?
|
| Occludin | 1 | 2011 | 7 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1745 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2011 | 25 | 0.050 |
Why?
|
| Attention | 1 | 2003 | 225 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 1851 | 0.050 |
Why?
|
| Cognitive Dysfunction | 1 | 2014 | 176 | 0.050 |
Why?
|
| Body Composition | 1 | 2011 | 119 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 161 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 296 | 0.040 |
Why?
|
| Sweden | 1 | 2009 | 21 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1553 | 0.040 |
Why?
|
| Learning | 1 | 2011 | 186 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2002 | 274 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2009 | 127 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2011 | 201 | 0.040 |
Why?
|
| Aged | 2 | 2015 | 14862 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2008 | 689 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2009 | 248 | 0.040 |
Why?
|
| Algorithms | 2 | 2014 | 1196 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2011 | 617 | 0.040 |
Why?
|
| Axonal Transport | 1 | 2006 | 9 | 0.040 |
Why?
|
| Choline O-Acetyltransferase | 2 | 2008 | 30 | 0.040 |
Why?
|
| Calbindins | 2 | 2008 | 23 | 0.040 |
Why?
|
| S100 Calcium Binding Protein G | 2 | 2008 | 21 | 0.040 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 11 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2010 | 332 | 0.030 |
Why?
|
| Voltage-Dependent Anion Channel 2 | 1 | 2016 | 9 | 0.030 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2016 | 10 | 0.030 |
Why?
|
| Chaperonin 60 | 1 | 2015 | 10 | 0.030 |
Why?
|
| Monoamine Oxidase | 1 | 2015 | 26 | 0.030 |
Why?
|
| Benzylamines | 1 | 2015 | 28 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 175 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2015 | 30 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2011 | 665 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2006 | 312 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 242 | 0.030 |
Why?
|
| Astrocytes | 2 | 2011 | 270 | 0.030 |
Why?
|
| Designer Drugs | 1 | 2015 | 7 | 0.030 |
Why?
|
| Colchicine | 1 | 2005 | 48 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 99 | 0.030 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2014 | 1 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 331 | 0.030 |
Why?
|
| Apoptosis | 2 | 2016 | 1641 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2014 | 85 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 260 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 79 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 122 | 0.030 |
Why?
|
| Protein Transport | 1 | 2005 | 280 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2014 | 94 | 0.030 |
Why?
|
| Head | 1 | 2013 | 59 | 0.030 |
Why?
|
| Cues | 2 | 2008 | 654 | 0.030 |
Why?
|
| Acetylcholinesterase | 1 | 2003 | 19 | 0.030 |
Why?
|
| Symporters | 1 | 2003 | 27 | 0.030 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2003 | 21 | 0.030 |
Why?
|
| Brain Stem | 1 | 2003 | 46 | 0.030 |
Why?
|
| Dendrites | 1 | 2003 | 44 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 517 | 0.030 |
Why?
|
| Cerebellum | 1 | 2003 | 103 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 1038 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1118 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Eating | 1 | 2011 | 119 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2003 | 682 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 92 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2010 | 77 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2010 | 114 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2010 | 102 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2010 | 128 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2077 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2008 | 34 | 0.020 |
Why?
|
| Coconut Oil | 1 | 2008 | 3 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2008 | 27 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 330 | 0.020 |
Why?
|
| Orientation | 1 | 2008 | 31 | 0.020 |
Why?
|
| Plant Oils | 1 | 2008 | 31 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2008 | 68 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2008 | 87 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2006 | 2689 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 213 | 0.020 |
Why?
|
| Adrenergic Agents | 1 | 2006 | 14 | 0.020 |
Why?
|
| Oxidopamine | 1 | 2006 | 42 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 499 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 700 | 0.020 |
Why?
|
| Middle Aged | 1 | 2014 | 21147 | 0.020 |
Why?
|
| Sucrose | 1 | 2005 | 58 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 122 | 0.020 |
Why?
|
| Anterior Eye Segment | 1 | 2005 | 13 | 0.020 |
Why?
|
| Calbindin 2 | 1 | 2004 | 6 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 786 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 50 | 0.010 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 2004 | 21 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 86 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2004 | 75 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 249 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 541 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 2003 | 25 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 52 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 710 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 328 | 0.010 |
Why?
|
| United States | 1 | 2014 | 7367 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 770 | 0.010 |
Why?
|
| Depression | 1 | 2008 | 943 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 954 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2673 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 5731 | 0.010 |
Why?
|